Cover Image
Market Research Report

Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Published by Transparency Market Research Product code 408268
Published Content info 162 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024
Published: November 18, 2016 Content info: 162 Pages
Description

Title: Hepatitis E Diagnostic Tests Market (Test Type - ELISA HEV IgM Test kits, ELISA HEV IgG Test Kits, and RT-PCR Test Kits; End User - Hospitals, Diagnostic Laboratories, Research Centers, and Point of Care) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024.

Global Hepatitis E Diagnostic Tests Market: Overview

Hepatitis E is a liver disease that is enterically transmitted and is caused by hepatitis E virus (HEV). It is one of the five known human hepatitis viruses (A, B, C, D, and E). Hepatitis E spreads through fecal-oral transmission due to fecal contamination of drinking water. The other routes of transmission of hepatitis E virus include transfusion of infected blood products, vertical transmission from a pregnant woman to her fetus, and ingestion of undercooked meat or meat products derived from infected animals. Infections with hepatitis E virus are commonly observed in regions with poor sanitation, including the Middle East, Asia, Central America, and Africa. The epidemiology and serology of HEV differs in developing and developed countries. It is considered to be rare in the U.S. and other developed regions.

Cases of hepatitis E are not clearly distinguishable from other types of viral hepatitis. Hence, diagnosis can be confirmed by testing the presence of RNA and antibodies against HEV. Testing for the presence of IgM and IgG is considered to be indirect tests and testing for the presence of HEV RNA is considered to be direct test. Presence of IgM is the primary test to identify acute infections in patients, which is confirmed by testing for the presence of RNA. Presence of IgG antibodies indicates that the patient has been exposed previously to hepatitis E virus.

This research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of hepatitis E diagnostic kits in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases.

Global Hepatitis E Diagnostic Tests Market: Scope of the Study

The report provides estimated market size in terms of US$ Mn for each test type, end user, and geography for the period 2014 to 2024, considering the macro and micro environmental factors. The revenue generated from each test type was calculated by considering sero-prevalence rate of hepatitis E, average selling price of the kits, trends in industry, end user trend, and adoption rate across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on test type, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the hepatitis E diagnostic tests market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved from identification of the market need to their final reach to the end users.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the hepatitis E diagnostic tests market.

Companies Mentioned in this report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the hepatitis E diagnostic tests market report are altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro - Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC., and Primerdesign Ltd., among others.

The Hepatitis E Diagnostic Tests Market has been segmented as follows:

By Test Type

  • ELISA HEV IgM Test kits
  • ELISA HEV IgG Test kits
  • RT-PCR Test kits
  • Others

By End User

  • Hospitals
  • Research Centers
  • Diagnostic Laboratories
  • Point of Care

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • A.E.
    • South Africa
    • Rest of Middle East and Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hepatitis E Diagnostic Tests Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Key Market Indicators
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, 2014-2024
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis
  • 4.6. Value Chain Analysis
    • 4.6.1. List of active market participants
  • 4.7. Disease Overview
  • 4.8. Regulatory approval process
  • 4.9. Market Outlook

5. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Test Type

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 5.4.1. HEV IgM ELISA Test kits
    • 5.4.2. HEV IgG ELISA Test kits
    • 5.4.3. RT-PCR Test kits
    • 5.4.4. Others
  • 5.5. Test Type Comparison Matrix
  • 5.6. Market Attractiveness, by Test Type

6. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By End User

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Laboratories
    • 6.4.3. Research Centers
    • 6.4.4. Point of Care
  • 6.5. End User Comparison Matrix
  • 6.6. Market Attractiveness by End User

7. Global Hepatitis E Diagnostic Tests Market Analysis and Forecasts, By Region

  • 7.1. Key Findings
  • 7.2. Market Value (US$ Mn) Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Attractiveness by Country/Region

8. North America Hepatitis E Diagnostic Tests Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
    • 8.1.2. Key Trends
  • 8.2. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 8.2.1. HEV IgM ELISA Test kits
    • 8.2.2. HEV IgG ELISA Test kits
    • 8.2.3. RT-PCR Test kits
    • 8.2.4. Others
  • 8.3. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Research Centers
    • 8.4.4. Others
  • 8.4. Market Value (US$ Mn) Forecast By Country, 2014-2024
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Test Type
    • 8.5.2. By End User
    • 8.5.3. By Country

9. Latin America Hepatitis E Diagnostic Tests Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Key Trends
  • 9.2. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 9.2.1. HEV IgM ELISA Test kits
    • 9.2.2. HEV IgG ELISA Test kits
    • 9.2.3. RT-PCR Test kits
    • 9.2.4. Others
  • 9.3. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Research Centers
    • 9.3.4. Point of Care
  • 9.4. Market Value (US$ Mn) Forecast By Country, 2014-2024
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Test Type
    • 9.5.2. By End User
    • 9.5.3. By Country

10. Europe Hepatitis E Diagnostic Tests Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Key Trends
  • 10.2. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 10.2.1. HEV IgM ELISA Test kits
    • 10.2.2. HEV IgG ELISA Test kits
    • 10.2.3. RT-PCR Test kits
    • 10.2.4. Others
  • 10.3. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Research Centers
    • 10.3.4. Point of Care
  • 10.4. Market Value (US$ Mn) Forecast By Country, 2014-2024
    • 10.4.1. UK
    • 10.4.2. Germany
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Test Type
    • 10.5.2. By End User
    • 10.5.3. By Country

11. Asia Pacific Hepatitis E Diagnostic Tests Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Key Trends
  • 11.2. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 11.2.1. HEV IgM ELISA Test kits
    • 11.2.2. HEV IgG ELISA Test kits
    • 11.2.3. RT-PCR Test kits
    • 11.2.4. Others
  • 11.3. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 11.3.1. Hospitals
    • 11.3.2. Diagnostic Laboratories
    • 11.3.3. Research Centers
    • 11.3.4. Point of Care
  • 11.4. Market Value (US$ Mn) Forecast By Country, 2014-2024
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Test Type
    • 11.5.2. By End User
    • 11.5.3. By Country

12. Middle East & Africa Hepatitis E Diagnostic Tests Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Key Trends
  • 12.2. Market Value (US$ Mn) Forecast By Test Type, 2014-2024
    • 12.2.1. HEV IgM ELISA Test kits
    • 12.2.2. HEV IgG ELISA Test kits
    • 12.2.3. RT-PCR Test kits
    • 12.2.4. Others
  • 12.3. Market Value (US$ Mn) Forecast By End User, 2014-2024
    • 12.3.1. Hospitals
    • 12.3.2. Diagnostic Laboratories
    • 12.3.3. Research Centers
    • 12.3.4. Point of Care
  • 12.4. Market Value (US$ Mn) Forecast By Country, 2014-2024
    • 12.4.1. South Africa
    • 12.4.2. UAE
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Test Type
    • 12.5.2. By End User
    • 12.5.3. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Market Share Analysis by Company (2015)
  • 13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 13.3.1. Altana Diagnostics GmbH
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Business Overview
      • 13.3.1.3. Product Portfolio
      • 13.3.1.4. Financial Overview
      • 13.3.1.5. SWOT Analysis
      • 13.3.1.6. Strategic overview
    • 13.3.2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Business Overview
      • 13.3.2.3. Product Portfolio
      • 13.3.2.4. Financial Overview
      • 13.3.2.5. SWOT Analysis
      • 13.3.2.6. Strategic overview
    • 13.3.3. Biokit S.A.
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Business Overview
      • 13.3.3.3. Product Portfolio
      • 13.3.3.4. Financial Overview
      • 13.3.3.5. SWOT Analysis
      • 13.3.3.6. Strategic overview
    • 13.3.4. Dia.Pro - Diagnostic Bioprobes s.r.l
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Business Overview
      • 13.3.4.3. Product Portfolio
      • 13.3.4.4. Financial Overview
      • 13.3.4.5. SWOT Analysis
      • 13.3.4.6. Strategic overview
    • 13.3.5. F. Hoffmann-La Roche Ltd.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Business Overview
      • 13.3.5.3. Product Portfolio
      • 13.3.5.4. Financial Overview
      • 13.3.5.5. SWOT Analysis
      • 13.3.5.6. Strategic overview
    • 13.3.6. Fast-track diagnostics Ltd.
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Business Overview
      • 13.3.6.3. Product Portfolio
      • 13.3.6.4. Financial Overview
      • 13.3.6.5. SWOT Analysis
      • 13.3.6.6. Strategic overview
    • 13.3.7. Fortress Diagnostics Limited
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Business Overview
      • 13.3.7.3. Product Portfolio
      • 13.3.7.4. Financial Overview
      • 13.3.7.5. SWOT Analysis
      • 13.3.7.6. Strategic overview
    • 13.3.8. Mikrogen GmBH
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Business Overview
      • 13.3.8.3. Product Portfolio
      • 13.3.8.4. Financial Overview
      • 13.3.8.5. SWOT Analysis
      • 13.3.8.6. Strategic overview
    • 13.3.9. MP Biomedicals, LLC.
      • 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.9.2. Business Overview
      • 13.3.9.3. Product Portfolio
      • 13.3.9.4. Financial Overview
      • 13.3.9.5. SWOT Analysis
      • 13.3.9.6. Strategic overview
    • 13.3.10. Primerdesign Ltd.
      • 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.10.2. Business Overview
      • 13.3.10.3. Product Portfolio
      • 13.3.10.4. Financial Overview
      • 13.3.10.5. SWOT Analysis
      • 13.3.10.6. Strategic overview

List of Figures

  • Figure 1: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) and Forecast, 2016-2024
  • Figure 02: Global Market Value Share, by Test Type (2016)
  • Figure 03: Global Market Value Share, by End-user (2016)
  • Figure 04: Global Market Value Share, by Region (2016)
  • Figure 05: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 06: Global ELISA HEV IgM Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 07: Global ELISA HEV IgG Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 08: Global ELISA RT-PCR Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 09: Global Others Test kits Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 10: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 11: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 12: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 13: Global Diagnostic Laboratories Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 14: Global Research Centers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 15: Global Point of Care Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2024
  • Figure 16: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
  • Figure 17: Global Hepatitis E Diagnostic Tests Market Revenue, US$ Mn, 2014-2024
  • Figure 18: Global Hepatitis E Diagnostic Tests Market Value Share Analysis, by Region, 2015 and 2024
  • Figure 19: Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Region, 2015
  • Figure 20: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 21: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
  • Figure 22: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 23: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
  • Figure 24: North America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 25: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 26: North America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
  • Figure 27: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 28: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
  • Figure 29: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 30: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 31: Europe Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 32: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 33: Europe Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
  • Figure 34: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 35: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
  • Figure 36: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 37: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-user, 2015 and 2024
  • Figure 38: Asia Pacific Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 39: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 40: Asia Pacific Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-user, 2015
  • Figure 41: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 42: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
  • Figure 43: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 44: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
  • Figure 45: Latin America Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 46: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 47: Latin America Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
  • Figure 48: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, 2014-2024
  • Figure 49: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Country, 2015
  • Figure 50: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Test Type, 2015 and 2024
  • Figure 51: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by End-User, 2015 and 2024
  • Figure 52: Middle East & Africa Hepatitis E Diagnostic Tests Market Value Share Analysis, by Country, 2015 and 2024
  • Figure 53: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by Test Type, 2015
  • Figure 54: Middle East & Africa Hepatitis E Diagnostic Tests Market Attractiveness Analysis, by End-User, 2015
  • Figure 55: Global Hepatitis E Diagnostic Tests Market Share Analysis, by Company (2015)

List of Tables

  • Table 01: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 02: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 03: Global Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Region, 2016-2024
  • Table 04: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 05: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016-2024
  • Table 06: North America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 07: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 08: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 09: Europe Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 10: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 11: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-user, 2016-2024
  • Table 12: Asia Pacific Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 13: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 14: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016-2024
  • Table 15: Latin America Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016-2024
  • Table 16: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Test Type, 2016-2024
  • Table 17: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by End-User, 2016-2024
  • Table 18: Middle East & Africa Hepatitis E Diagnostic Tests Market Size (US$ Mn) Forecast, by Country, 2016-2024
Back to Top